Key facts
| Legal name | Diversified Pharmacy Inc. (doing business as MediVera Compounding Pharmacy) |
|---|---|
| Location | 5225 Crooks Rd, Troy, MI 48098 |
| Type | 503A compounding pharmacy |
| On FDA 503B list | No |
| Accreditations it claims | PCAB, sterile and non-sterile, since 2017 — not independently verified |
| States | Says it is licensed in 49 states |
| GLP-1 products it lists | Compounded liraglutide injection (current page); semaglutide mentioned in a 2024 post |
| FDA actions 2023–2026 | None found |
| History | Rebranded from University Compounding Pharmacy on July 1, 2024 |
GLP-1 products
MediVera’s current page lists compounded liraglutide injection and sermorelin; semaglutide appears only in a 2024 post. Ask the prescribing program what the label will say before relying on it for semaglutide.
Record and accreditation
We found no FDA warning letter, Form 483 or recall for MediVera from 2023 to October 14, 2026. Its PCAB accreditation (sterile and non-sterile, since 2017) is its own claim; we did not confirm it with ACHC.
How to check any compounding pharmacy
Read the pharmacy name on your vial label, look it up with the board of pharmacy in your state, check FDA’s outsourcing-facility list if it claims 503B status, and search FDA’s warning-letter database by name. Our 503A vs 503B guide explains the difference.
Questions about MediVera Compounding Pharmacy
Is MediVera the same as University Compounding Pharmacy?
Yes. The business, Diversified Pharmacy Inc., rebranded on July 1, 2024.
Does MediVera compound semaglutide?
Not on its current weight-loss page, which lists liraglutide. A 2024 post mentions semaglutide.
Sources
A Form 483 records an inspector’s observations and is not a final agency finding. Compounded drugs are not FDA-approved. This profile is informational and is not an endorsement.